3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Giant Cell Tumor of Tendon Sheath
2
Synovitis, Pigmented Villonodular
1
Interventions
pexidartinib
1
emactuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Synovitis, Pigmented Villonodular
×
pexidartinib
×
Clear all
NCT02371369
2022-05-11
ENLIVEN
Daiichi Sankyo
Phase 3
Completed
120 enrolled
25 charts
1 FDA